Mini-Monograph Archive

---

Rat Uterotrophic Bioassay
111:1527-1570 (2003)

• The OECD Program to Validate the Rat Uterotrophic Bioassay: An Overview
• The OECD Program to Validate the Rat Uterotrophic Bioassay. Phase 2: Dose-Response Studies
• The OECD Program to Validate the Rat Uterotrophic Bioassay. Phase 2: Coded Single-Dose Studies
• The OECD Program to Validate the Rat Uterotrophic Bioassay. Phase 2: Dietary Phytoestrogen Analyses
• The Intact Immature Rodent Uterotrophic Bioassay: Possible Effects on Assay Sensitivity of Vomeronasal Signals from Male Rodents and Strain Differences

---

Regulatory Acceptance of (Q)SARs 111:1358-1401 (2003)

• Summary of a Workshop on Regulatory Acceptance of (Q)SARs for Human Health and Environmental Endpoints
• Methods for Reliability and Uncertainty Assessment and for Applicability Evaluations of Classification- and Regression-Based QSARs
• Use of QSARs in International Decision-Making Frameworks to Predict Ecologic Effects and Environmental Fate of Chemical Substances
• Use of QSARs in International Decision-Making Frameworks to Predict Health Effects of Chemical Substances

---

Genetically Modified Foods
111:1110-1141 (2003)

• Introduction: What Are the Issues in Addressing the Allergenic Potential of Genetically Modified Foods?
• Clinical and Laboratory Investigation of Allergy to Genetically Modified Foods
• Protein Digestibility and Relevance to Allergenicity
• Assessment of Protein Allergenicity on the Basis of Immune Reactivity: Animal Models
• Key Issues for the Assessment of the Allergenic Potential of Genetically Modified Foods: Breakout Group Reports
• Assessment of Allergenic Potential of Genetically Modified Foods: An Agenda for Future Research

---

World Trade Center
111:971-991 (2003)

• World Trade Center Fine Particulate Matter--Chemistry and Toxic Respiratory Effects: An Overview
• Chemical Analysis of World Trade Center Fine Particulate Matter for Use in Toxicologic Assessment
• World Trade Center Fine Particulate Matter Causes Respiratory Tract Hyperresponsiveness in Mice

---

Green Pharmacy
111:757-785 (2003)

• Cradle-to-Cradle Stewardship of Drugs for Minimizing Their Environmental Disposition While Promoting Human Health. I. Rationale for and Avenues toward a Green Pharmacy
• Cradle-to-Cradle Stewardship of Drugs for Minimizing Their Environmental Disposition While Promoting Human Health. II. Drug Disposal, Waste Reduction, and Future Directions

---

Allergenicity Models
111:221-254 (2003)

• Animal Models to Detect Allergenicity to Foods and Genetically Modified Products: Workshop Summary
• Food Allergy: An Overview
• Assessment of the Inherent Allergenic Potential of Proteins in Mice
• Assessment of the Allergic Potential of Food Protein Extracts and Proteins on Oral Application Using the Brown Norway Rat Model
• Nonmurine Animal Models of Food Allergy
• Identification of Antigenic Epitopes on Human Allergens: Studies with HLA Transgenic Mice
• A Human Dendritic Cell-Based Method to Identify CD4⁺ T-Cell Epitopes in Potential Protein Allergens

---

Chemical Contaminants in Breast Milk: Impacts on Children's Health
110:A313-A351 (2002)

• Chemical Contaminants in Breast Milk and Their Impacts on Children's Health: An Overview
• Analytic Considerations for Measuring Environmental Chemicals in Breast Milk
• Infant Exposure to Dioxin-like Compounds in Breast Milk
• Pharmacokinetics of Toxic Chemicals in Breast Milk: Use of PBPK Models to Predict Infant Exposure
• Chemical Contaminants in Breast Milk: Time Trends and Regional Variability
• Global Perspectives in Breast Milk Contamination: Infectious and Toxic Hazards